nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—CYP2C18—Dapsone—malaria	0.0596	0.0807	CbGbCtD
Lansoprazole—CYP2C8—Sulfadiazine—malaria	0.0366	0.0495	CbGbCtD
Lansoprazole—CYP2C8—Pyrimethamine—malaria	0.0366	0.0495	CbGbCtD
Lansoprazole—CYP1A1—Quinine—malaria	0.0327	0.0442	CbGbCtD
Lansoprazole—CYP1A1—Quinidine—malaria	0.0287	0.0388	CbGbCtD
Lansoprazole—CYP2C19—Artemether—malaria	0.0261	0.0353	CbGbCtD
Lansoprazole—CYP3A4—Clindamycin—malaria	0.0258	0.035	CbGbCtD
Lansoprazole—CYP2C9—Pyrimethamine—malaria	0.0255	0.0345	CbGbCtD
Lansoprazole—CYP2C9—Sulfadiazine—malaria	0.0255	0.0345	CbGbCtD
Lansoprazole—CYP2C19—Proguanil—malaria	0.0245	0.0332	CbGbCtD
Lansoprazole—CYP2D6—Pyrimethamine—malaria	0.0233	0.0316	CbGbCtD
Lansoprazole—CYP1A2—Proguanil—malaria	0.0226	0.0306	CbGbCtD
Lansoprazole—CYP2C9—Artemether—malaria	0.0217	0.0294	CbGbCtD
Lansoprazole—CYP2C9—Proguanil—malaria	0.0204	0.0276	CbGbCtD
Lansoprazole—CYP2D6—Artemether—malaria	0.0198	0.0268	CbGbCtD
Lansoprazole—CYP2C8—Quinine—malaria	0.0188	0.0255	CbGbCtD
Lansoprazole—CYP2D6—Proguanil—malaria	0.0187	0.0252	CbGbCtD
Lansoprazole—CYP2D6—Quinidine barbiturate—malaria	0.0177	0.0239	CbGbCtD
Lansoprazole—CYP2C8—Quinidine—malaria	0.0166	0.0224	CbGbCtD
Lansoprazole—CYP1A2—Pentoxifylline—malaria	0.0163	0.022	CbGbCtD
Lansoprazole—CYP2C19—Quinine—malaria	0.0158	0.0214	CbGbCtD
Lansoprazole—CYP3A4—Sulfadiazine—malaria	0.0148	0.0201	CbGbCtD
Lansoprazole—CYP1A2—Quinine—malaria	0.0146	0.0197	CbGbCtD
Lansoprazole—CYP2C8—Dapsone—malaria	0.0143	0.0193	CbGbCtD
Lansoprazole—CYP2C9—Quinine—malaria	0.0131	0.0178	CbGbCtD
Lansoprazole—CYP1A2—Quinidine—malaria	0.0128	0.0174	CbGbCtD
Lansoprazole—ABCB1—Quinine—malaria	0.0128	0.0173	CbGbCtD
Lansoprazole—CYP3A4—Artemether—malaria	0.0126	0.0171	CbGbCtD
Lansoprazole—CYP2D6—Quinine—malaria	0.012	0.0163	CbGbCtD
Lansoprazole—CYP2C19—Dapsone—malaria	0.012	0.0162	CbGbCtD
Lansoprazole—CYP3A4—Proguanil—malaria	0.0119	0.0161	CbGbCtD
Lansoprazole—CYP2C9—Quinidine—malaria	0.0116	0.0156	CbGbCtD
Lansoprazole—CYP3A4—Doxycycline—malaria	0.0112	0.0152	CbGbCtD
Lansoprazole—ABCB1—Quinidine—malaria	0.0112	0.0152	CbGbCtD
Lansoprazole—CYP2D6—Quinidine—malaria	0.0106	0.0143	CbGbCtD
Lansoprazole—CYP2C9—Dapsone—malaria	0.00996	0.0135	CbGbCtD
Lansoprazole—CYP3A4—Quinine—malaria	0.00764	0.0103	CbGbCtD
Lansoprazole—CYP3A4—Quinidine—malaria	0.00672	0.00909	CbGbCtD
Lansoprazole—CYP3A4—Dapsone—malaria	0.00579	0.00784	CbGbCtD
Lansoprazole—ATP4A—blood plasma—malaria	0.0048	0.0705	CbGeAlD
Lansoprazole—ATP4B—digestive system—malaria	0.00424	0.0622	CbGeAlD
Lansoprazole—ATP4B—liver—malaria	0.00316	0.0464	CbGeAlD
Lansoprazole—CYP4A11—kidney—malaria	0.0027	0.0396	CbGeAlD
Lansoprazole—ATP4A—hematopoietic system—malaria	0.00265	0.039	CbGeAlD
Lansoprazole—CYP4A11—digestive system—malaria	0.00229	0.0336	CbGeAlD
Lansoprazole—ATP4A—kidney—malaria	0.00218	0.0319	CbGeAlD
Lansoprazole—ATP4A—digestive system—malaria	0.00185	0.0271	CbGeAlD
Lansoprazole—ATP4A—blood—malaria	0.00176	0.0258	CbGeAlD
Lansoprazole—CYP4A11—liver—malaria	0.00171	0.025	CbGeAlD
Lansoprazole—CYP2C19—blood plasma—malaria	0.00168	0.0246	CbGeAlD
Lansoprazole—CYP2C18—digestive system—malaria	0.00152	0.0223	CbGeAlD
Lansoprazole—MAPT—brain—malaria	0.00147	0.0216	CbGeAlD
Lansoprazole—CYP2C8—blood plasma—malaria	0.00146	0.0215	CbGeAlD
Lansoprazole—ATP4A—liver—malaria	0.00137	0.0202	CbGeAlD
Lansoprazole—CYP1A2—blood plasma—malaria	0.00137	0.0201	CbGeAlD
Lansoprazole—CYP2C9—blood plasma—malaria	0.0013	0.0191	CbGeAlD
Lansoprazole—CYP2C18—liver—malaria	0.00113	0.0166	CbGeAlD
Lansoprazole—ATP4A—brain—malaria	0.00109	0.016	CbGeAlD
Lansoprazole—CYP1B1—hematopoietic system—malaria	0.00106	0.0155	CbGeAlD
Lansoprazole—CYP3A4—blood plasma—malaria	0.000991	0.0145	CbGeAlD
Lansoprazole—CYP2D6—blood plasma—malaria	0.000975	0.0143	CbGeAlD
Lansoprazole—CYP2C19—hematopoietic system—malaria	0.000927	0.0136	CbGeAlD
Lansoprazole—CYP1B1—kidney—malaria	0.000866	0.0127	CbGeAlD
Lansoprazole—ABCG2—saliva-secreting gland—malaria	0.000824	0.0121	CbGeAlD
Lansoprazole—CYP2C8—hematopoietic system—malaria	0.000809	0.0119	CbGeAlD
Lansoprazole—CYP1A2—hematopoietic system—malaria	0.000757	0.0111	CbGeAlD
Lansoprazole—CYP1A1—hematopoietic system—malaria	0.000747	0.011	CbGeAlD
Lansoprazole—CYP1B1—digestive system—malaria	0.000735	0.0108	CbGeAlD
Lansoprazole—CYP2C9—hematopoietic system—malaria	0.000719	0.0105	CbGeAlD
Lansoprazole—ABCB1—blood plasma—malaria	0.000702	0.0103	CbGeAlD
Lansoprazole—CYP1B1—blood—malaria	0.0007	0.0103	CbGeAlD
Lansoprazole—CYP2C8—kidney—malaria	0.000663	0.00974	CbGeAlD
Lansoprazole—CYP2C19—digestive system—malaria	0.000645	0.00946	CbGeAlD
Lansoprazole—CYP2C19—blood—malaria	0.000614	0.00902	CbGeAlD
Lansoprazole—CYP1A1—kidney—malaria	0.000612	0.00899	CbGeAlD
Lansoprazole—CYP3A4—hematopoietic system—malaria	0.000548	0.00804	CbGeAlD
Lansoprazole—CYP1B1—liver—malaria	0.000547	0.00803	CbGeAlD
Lansoprazole—CYP2D6—hematopoietic system—malaria	0.000539	0.00792	CbGeAlD
Lansoprazole—CYP2C8—blood—malaria	0.000536	0.00787	CbGeAlD
Lansoprazole—CYP1A2—digestive system—malaria	0.000527	0.00773	CbGeAlD
Lansoprazole—ABCG2—blood—malaria	0.000521	0.00765	CbGeAlD
Lansoprazole—CYP1A1—digestive system—malaria	0.000519	0.00762	CbGeAlD
Lansoprazole—ABCG2—bone marrow—malaria	0.000504	0.0074	CbGeAlD
Lansoprazole—CYP1A2—blood—malaria	0.000502	0.00736	CbGeAlD
Lansoprazole—CYP2C9—digestive system—malaria	0.0005	0.00734	CbGeAlD
Lansoprazole—CYP1A1—blood—malaria	0.000495	0.00726	CbGeAlD
Lansoprazole—CYP2C19—liver—malaria	0.00048	0.00705	CbGeAlD
Lansoprazole—CYP2C9—blood—malaria	0.000476	0.00699	CbGeAlD
Lansoprazole—CYP3A4—kidney—malaria	0.000449	0.00659	CbGeAlD
Lansoprazole—CYP2D6—kidney—malaria	0.000442	0.00649	CbGeAlD
Lansoprazole—CYP1B1—brain—malaria	0.000434	0.00638	CbGeAlD
Lansoprazole—CYP2C8—liver—malaria	0.000419	0.00615	CbGeAlD
Lansoprazole—ABCG2—liver—malaria	0.000408	0.00598	CbGeAlD
Lansoprazole—CYP1A2—liver—malaria	0.000392	0.00576	CbGeAlD
Lansoprazole—ABCB1—hematopoietic system—malaria	0.000388	0.00569	CbGeAlD
Lansoprazole—CYP1A1—liver—malaria	0.000387	0.00568	CbGeAlD
Lansoprazole—CYP3A4—digestive system—malaria	0.000381	0.00559	CbGeAlD
Lansoprazole—CYP2D6—digestive system—malaria	0.000375	0.00551	CbGeAlD
Lansoprazole—CYP2C9—liver—malaria	0.000372	0.00547	CbGeAlD
Lansoprazole—CYP3A4—blood—malaria	0.000363	0.00533	CbGeAlD
Lansoprazole—CYP2D6—blood—malaria	0.000357	0.00524	CbGeAlD
Lansoprazole—CYP2C8—brain—malaria	0.000333	0.00488	CbGeAlD
Lansoprazole—ABCG2—brain—malaria	0.000323	0.00475	CbGeAlD
Lansoprazole—ABCB1—kidney—malaria	0.000318	0.00467	CbGeAlD
Lansoprazole—CYP1A1—brain—malaria	0.000307	0.00451	CbGeAlD
Lansoprazole—CYP3A4—liver—malaria	0.000284	0.00417	CbGeAlD
Lansoprazole—CYP2D6—liver—malaria	0.000279	0.0041	CbGeAlD
Lansoprazole—ABCB1—digestive system—malaria	0.00027	0.00396	CbGeAlD
Lansoprazole—ABCB1—blood—malaria	0.000257	0.00377	CbGeAlD
Lansoprazole—ABCB1—bone marrow—malaria	0.000249	0.00365	CbGeAlD
Lansoprazole—Gastrointestinal disorder—Sulfadiazine—malaria	0.000223	0.00117	CcSEcCtD
Lansoprazole—Cardiac disorder—Quinidine barbiturate—malaria	0.000223	0.00116	CcSEcCtD
Lansoprazole—CYP2D6—brain—malaria	0.000222	0.00325	CbGeAlD
Lansoprazole—Vertigo—Dapsone—malaria	0.000219	0.00114	CcSEcCtD
Lansoprazole—Vision blurred—Quinidine—malaria	0.000218	0.00114	CcSEcCtD
Lansoprazole—Vision blurred—Quinine—malaria	0.000218	0.00114	CcSEcCtD
Lansoprazole—Anaemia—Clindamycin—malaria	0.000218	0.00114	CcSEcCtD
Lansoprazole—Tremor—Quinine—malaria	0.000217	0.00113	CcSEcCtD
Lansoprazole—Tremor—Quinidine—malaria	0.000217	0.00113	CcSEcCtD
Lansoprazole—Immune system disorder—Quinidine barbiturate—malaria	0.000217	0.00113	CcSEcCtD
Lansoprazole—Immune system disorder—Pentoxifylline—malaria	0.000216	0.00113	CcSEcCtD
Lansoprazole—Mediastinal disorder—Quinidine barbiturate—malaria	0.000216	0.00113	CcSEcCtD
Lansoprazole—Chills—Quinidine barbiturate—malaria	0.000215	0.00112	CcSEcCtD
Lansoprazole—Arrhythmia—Pentoxifylline—malaria	0.000214	0.00112	CcSEcCtD
Lansoprazole—Cough—Dapsone—malaria	0.000213	0.00111	CcSEcCtD
Lansoprazole—Agitation—Quinine—malaria	0.000213	0.00111	CcSEcCtD
Lansoprazole—Agitation—Quinidine—malaria	0.000213	0.00111	CcSEcCtD
Lansoprazole—Vertigo—Clindamycin—malaria	0.000212	0.00111	CcSEcCtD
Lansoprazole—Angioedema—Quinine—malaria	0.000211	0.0011	CcSEcCtD
Lansoprazole—Angioedema—Quinidine—malaria	0.000211	0.0011	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Sulfadiazine—malaria	0.000211	0.0011	CcSEcCtD
Lansoprazole—Leukopenia—Clindamycin—malaria	0.000211	0.0011	CcSEcCtD
Lansoprazole—Mental disorder—Quinidine barbiturate—malaria	0.00021	0.0011	CcSEcCtD
Lansoprazole—Malnutrition—Quinidine barbiturate—malaria	0.000209	0.00109	CcSEcCtD
Lansoprazole—Erythema—Quinidine barbiturate—malaria	0.000209	0.00109	CcSEcCtD
Lansoprazole—Erythema—Pentoxifylline—malaria	0.000208	0.00109	CcSEcCtD
Lansoprazole—Vertigo—Quinidine—malaria	0.000208	0.00109	CcSEcCtD
Lansoprazole—Vertigo—Quinine—malaria	0.000208	0.00109	CcSEcCtD
Lansoprazole—Syncope—Quinidine—malaria	0.000207	0.00108	CcSEcCtD
Lansoprazole—Syncope—Quinine—malaria	0.000207	0.00108	CcSEcCtD
Lansoprazole—Leukopenia—Quinine—malaria	0.000207	0.00108	CcSEcCtD
Lansoprazole—Leukopenia—Quinidine—malaria	0.000207	0.00108	CcSEcCtD
Lansoprazole—Flatulence—Pentoxifylline—malaria	0.000205	0.00107	CcSEcCtD
Lansoprazole—Urticaria—Sulfadiazine—malaria	0.000205	0.00107	CcSEcCtD
Lansoprazole—Tension—Quinidine barbiturate—malaria	0.000205	0.00107	CcSEcCtD
Lansoprazole—Tension—Pentoxifylline—malaria	0.000204	0.00107	CcSEcCtD
Lansoprazole—Palpitations—Quinidine—malaria	0.000204	0.00107	CcSEcCtD
Lansoprazole—Palpitations—Quinine—malaria	0.000204	0.00107	CcSEcCtD
Lansoprazole—Body temperature increased—Sulfadiazine—malaria	0.000204	0.00107	CcSEcCtD
Lansoprazole—Abdominal pain—Sulfadiazine—malaria	0.000204	0.00107	CcSEcCtD
Lansoprazole—Dysgeusia—Pentoxifylline—malaria	0.000204	0.00107	CcSEcCtD
Lansoprazole—Hypertension—Clindamycin—malaria	0.000204	0.00106	CcSEcCtD
Lansoprazole—Loss of consciousness—Quinine—malaria	0.000203	0.00106	CcSEcCtD
Lansoprazole—Loss of consciousness—Quinidine—malaria	0.000203	0.00106	CcSEcCtD
Lansoprazole—Nervousness—Quinidine barbiturate—malaria	0.000203	0.00106	CcSEcCtD
Lansoprazole—Nervousness—Pentoxifylline—malaria	0.000202	0.00106	CcSEcCtD
Lansoprazole—Back pain—Pentoxifylline—malaria	0.000202	0.00105	CcSEcCtD
Lansoprazole—ABCB1—liver—malaria	0.000201	0.00295	CbGeAlD
Lansoprazole—Convulsion—Quinidine—malaria	0.0002	0.00105	CcSEcCtD
Lansoprazole—Convulsion—Quinine—malaria	0.0002	0.00105	CcSEcCtD
Lansoprazole—Muscle spasms—Pentoxifylline—malaria	0.0002	0.00105	CcSEcCtD
Lansoprazole—Discomfort—Clindamycin—malaria	0.000198	0.00104	CcSEcCtD
Lansoprazole—Chest pain—Quinidine—malaria	0.000197	0.00103	CcSEcCtD
Lansoprazole—Myalgia—Quinidine—malaria	0.000197	0.00103	CcSEcCtD
Lansoprazole—Chest pain—Quinine—malaria	0.000197	0.00103	CcSEcCtD
Lansoprazole—Myalgia—Quinine—malaria	0.000197	0.00103	CcSEcCtD
Lansoprazole—Vision blurred—Quinidine barbiturate—malaria	0.000197	0.00103	CcSEcCtD
Lansoprazole—Vision blurred—Pentoxifylline—malaria	0.000196	0.00103	CcSEcCtD
Lansoprazole—Tremor—Quinidine barbiturate—malaria	0.000196	0.00102	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000196	0.00102	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000196	0.00102	CcSEcCtD
Lansoprazole—Tremor—Pentoxifylline—malaria	0.000195	0.00102	CcSEcCtD
Lansoprazole—Tachycardia—Dapsone—malaria	0.000194	0.00101	CcSEcCtD
Lansoprazole—Ill-defined disorder—Pentoxifylline—malaria	0.000193	0.00101	CcSEcCtD
Lansoprazole—Anaemia—Pentoxifylline—malaria	0.000193	0.00101	CcSEcCtD
Lansoprazole—Anaphylactic shock—Clindamycin—malaria	0.000192	0.00101	CcSEcCtD
Lansoprazole—Agitation—Quinidine barbiturate—malaria	0.000192	0.001	CcSEcCtD
Lansoprazole—Agitation—Pentoxifylline—malaria	0.000191	0.001	CcSEcCtD
Lansoprazole—Angioedema—Quinidine barbiturate—malaria	0.000191	0.000997	CcSEcCtD
Lansoprazole—Angioedema—Pentoxifylline—malaria	0.00019	0.000995	CcSEcCtD
Lansoprazole—Hypersensitivity—Sulfadiazine—malaria	0.00019	0.000995	CcSEcCtD
Lansoprazole—Confusional state—Quinine—malaria	0.00019	0.000995	CcSEcCtD
Lansoprazole—Confusional state—Quinidine—malaria	0.00019	0.000995	CcSEcCtD
Lansoprazole—Oedema—Quinine—malaria	0.000189	0.000987	CcSEcCtD
Lansoprazole—Oedema—Quinidine—malaria	0.000189	0.000987	CcSEcCtD
Lansoprazole—Thrombocytopenia—Clindamycin—malaria	0.000188	0.000985	CcSEcCtD
Lansoprazole—Malaise—Pentoxifylline—malaria	0.000188	0.000982	CcSEcCtD
Lansoprazole—Vertigo—Quinidine barbiturate—malaria	0.000188	0.00098	CcSEcCtD
Lansoprazole—Syncope—Quinidine barbiturate—malaria	0.000187	0.000978	CcSEcCtD
Lansoprazole—Leukopenia—Quinidine barbiturate—malaria	0.000187	0.000977	CcSEcCtD
Lansoprazole—Leukopenia—Pentoxifylline—malaria	0.000186	0.000975	CcSEcCtD
Lansoprazole—Shock—Quinidine—malaria	0.000186	0.000971	CcSEcCtD
Lansoprazole—Shock—Quinine—malaria	0.000186	0.000971	CcSEcCtD
Lansoprazole—Nervous system disorder—Quinine—malaria	0.000185	0.000968	CcSEcCtD
Lansoprazole—Nervous system disorder—Quinidine—malaria	0.000185	0.000968	CcSEcCtD
Lansoprazole—Thrombocytopenia—Quinine—malaria	0.000185	0.000966	CcSEcCtD
Lansoprazole—Thrombocytopenia—Quinidine—malaria	0.000185	0.000966	CcSEcCtD
Lansoprazole—Palpitations—Quinidine barbiturate—malaria	0.000184	0.000964	CcSEcCtD
Lansoprazole—Tachycardia—Quinine—malaria	0.000184	0.000963	CcSEcCtD
Lansoprazole—Tachycardia—Quinidine—malaria	0.000184	0.000963	CcSEcCtD
Lansoprazole—Palpitations—Pentoxifylline—malaria	0.000184	0.000962	CcSEcCtD
Lansoprazole—Loss of consciousness—Quinidine barbiturate—malaria	0.000183	0.000959	CcSEcCtD
Lansoprazole—Skin disorder—Quinidine—malaria	0.000183	0.000958	CcSEcCtD
Lansoprazole—Skin disorder—Quinine—malaria	0.000183	0.000958	CcSEcCtD
Lansoprazole—Pruritus—Sulfadiazine—malaria	0.000183	0.000956	CcSEcCtD
Lansoprazole—Hyperhidrosis—Quinidine—malaria	0.000182	0.000954	CcSEcCtD
Lansoprazole—Hyperhidrosis—Quinine—malaria	0.000182	0.000954	CcSEcCtD
Lansoprazole—MAPT—IL-2 Signaling Pathway—CISH—malaria	0.000181	0.112	CbGpPWpGaD
Lansoprazole—Convulsion—Quinidine barbiturate—malaria	0.000181	0.000945	CcSEcCtD
Lansoprazole—Convulsion—Pentoxifylline—malaria	0.000181	0.000944	CcSEcCtD
Lansoprazole—Anorexia—Quinine—malaria	0.00018	0.000941	CcSEcCtD
Lansoprazole—Anorexia—Quinidine—malaria	0.00018	0.000941	CcSEcCtD
Lansoprazole—Insomnia—Dapsone—malaria	0.00018	0.00094	CcSEcCtD
Lansoprazole—Hypertension—Pentoxifylline—malaria	0.00018	0.00094	CcSEcCtD
Lansoprazole—Hypotension—Clindamycin—malaria	0.00018	0.00094	CcSEcCtD
Lansoprazole—Chest pain—Quinidine barbiturate—malaria	0.000178	0.000929	CcSEcCtD
Lansoprazole—Arthralgia—Quinidine barbiturate—malaria	0.000178	0.000929	CcSEcCtD
Lansoprazole—Myalgia—Quinidine barbiturate—malaria	0.000178	0.000929	CcSEcCtD
Lansoprazole—Chest pain—Pentoxifylline—malaria	0.000177	0.000927	CcSEcCtD
Lansoprazole—Myalgia—Pentoxifylline—malaria	0.000177	0.000927	CcSEcCtD
Lansoprazole—Anxiety—Quinidine barbiturate—malaria	0.000177	0.000926	CcSEcCtD
Lansoprazole—Diarrhoea—Sulfadiazine—malaria	0.000177	0.000924	CcSEcCtD
Lansoprazole—Anxiety—Pentoxifylline—malaria	0.000177	0.000924	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000176	0.000923	CcSEcCtD
Lansoprazole—Hypotension—Quinidine—malaria	0.000176	0.000922	CcSEcCtD
Lansoprazole—Hypotension—Quinine—malaria	0.000176	0.000922	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000176	0.000921	CcSEcCtD
Lansoprazole—Discomfort—Pentoxifylline—malaria	0.000175	0.000916	CcSEcCtD
Lansoprazole—Dry mouth—Pentoxifylline—malaria	0.000173	0.000907	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Quinine—malaria	0.000172	0.000899	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Quinidine—malaria	0.000172	0.000899	CcSEcCtD
Lansoprazole—Confusional state—Quinidine barbiturate—malaria	0.000172	0.000898	CcSEcCtD
Lansoprazole—Dyspnoea—Clindamycin—malaria	0.000172	0.000897	CcSEcCtD
Lansoprazole—Confusional state—Pentoxifylline—malaria	0.000171	0.000896	CcSEcCtD
Lansoprazole—Oedema—Quinidine barbiturate—malaria	0.00017	0.00089	CcSEcCtD
Lansoprazole—Oedema—Pentoxifylline—malaria	0.00017	0.000889	CcSEcCtD
Lansoprazole—Anaphylactic shock—Pentoxifylline—malaria	0.00017	0.000889	CcSEcCtD
Lansoprazole—Dyspepsia—Clindamycin—malaria	0.000169	0.000885	CcSEcCtD
Lansoprazole—Infection—Pentoxifylline—malaria	0.000169	0.000883	CcSEcCtD
Lansoprazole—Dyspnoea—Quinidine—malaria	0.000168	0.00088	CcSEcCtD
Lansoprazole—Dyspnoea—Quinine—malaria	0.000168	0.00088	CcSEcCtD
Lansoprazole—Shock—Quinidine barbiturate—malaria	0.000168	0.000876	CcSEcCtD
Lansoprazole—Shock—Pentoxifylline—malaria	0.000167	0.000875	CcSEcCtD
Lansoprazole—Nervous system disorder—Quinidine barbiturate—malaria	0.000167	0.000873	CcSEcCtD
Lansoprazole—Thrombocytopenia—Quinidine barbiturate—malaria	0.000167	0.000872	CcSEcCtD
Lansoprazole—Thrombocytopenia—Pentoxifylline—malaria	0.000166	0.00087	CcSEcCtD
Lansoprazole—Tachycardia—Quinidine barbiturate—malaria	0.000166	0.000869	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Clindamycin—malaria	0.000166	0.000868	CcSEcCtD
Lansoprazole—Tachycardia—Pentoxifylline—malaria	0.000166	0.000868	CcSEcCtD
Lansoprazole—Fatigue—Clindamycin—malaria	0.000166	0.000867	CcSEcCtD
Lansoprazole—Skin disorder—Quinidine barbiturate—malaria	0.000165	0.000865	CcSEcCtD
Lansoprazole—Skin disorder—Pentoxifylline—malaria	0.000165	0.000863	CcSEcCtD
Lansoprazole—Hyperhidrosis—Quinidine barbiturate—malaria	0.000165	0.000861	CcSEcCtD
Lansoprazole—Pain—Clindamycin—malaria	0.000165	0.00086	CcSEcCtD
Lansoprazole—Constipation—Clindamycin—malaria	0.000165	0.00086	CcSEcCtD
Lansoprazole—Hyperhidrosis—Pentoxifylline—malaria	0.000164	0.000859	CcSEcCtD
Lansoprazole—Vomiting—Sulfadiazine—malaria	0.000164	0.000859	CcSEcCtD
Lansoprazole—Decreased appetite—Quinine—malaria	0.000164	0.000858	CcSEcCtD
Lansoprazole—Decreased appetite—Quinidine—malaria	0.000164	0.000858	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Quinine—malaria	0.000163	0.000852	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Quinidine—malaria	0.000163	0.000852	CcSEcCtD
Lansoprazole—Rash—Sulfadiazine—malaria	0.000163	0.000852	CcSEcCtD
Lansoprazole—Dermatitis—Sulfadiazine—malaria	0.000163	0.000851	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Dapsone—malaria	0.000163	0.00085	CcSEcCtD
Lansoprazole—Anorexia—Quinidine barbiturate—malaria	0.000162	0.000849	CcSEcCtD
Lansoprazole—Anorexia—Pentoxifylline—malaria	0.000162	0.000847	CcSEcCtD
Lansoprazole—Headache—Sulfadiazine—malaria	0.000162	0.000846	CcSEcCtD
Lansoprazole—ABCB1—brain—malaria	0.000159	0.00234	CbGeAlD
Lansoprazole—Hypotension—Quinidine barbiturate—malaria	0.000159	0.000832	CcSEcCtD
Lansoprazole—Hypotension—Pentoxifylline—malaria	0.000159	0.000831	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Clindamycin—malaria	0.000157	0.000822	CcSEcCtD
Lansoprazole—Body temperature increased—Dapsone—malaria	0.000157	0.000822	CcSEcCtD
Lansoprazole—Abdominal pain—Dapsone—malaria	0.000157	0.000822	CcSEcCtD
Lansoprazole—Feeling abnormal—Quinine—malaria	0.000156	0.000813	CcSEcCtD
Lansoprazole—Feeling abnormal—Quinidine—malaria	0.000156	0.000813	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000155	0.000811	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000155	0.00081	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Quinine—malaria	0.000154	0.000807	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Quinidine—malaria	0.000154	0.000807	CcSEcCtD
Lansoprazole—Insomnia—Pentoxifylline—malaria	0.000154	0.000804	CcSEcCtD
Lansoprazole—Nausea—Sulfadiazine—malaria	0.000153	0.000802	CcSEcCtD
Lansoprazole—Urticaria—Clindamycin—malaria	0.000153	0.000799	CcSEcCtD
Lansoprazole—Body temperature increased—Clindamycin—malaria	0.000152	0.000795	CcSEcCtD
Lansoprazole—Abdominal pain—Clindamycin—malaria	0.000152	0.000795	CcSEcCtD
Lansoprazole—Dyspnoea—Quinidine barbiturate—malaria	0.000152	0.000794	CcSEcCtD
Lansoprazole—Dyspnoea—Pentoxifylline—malaria	0.000152	0.000792	CcSEcCtD
Lansoprazole—Somnolence—Quinidine barbiturate—malaria	0.000151	0.000792	CcSEcCtD
Lansoprazole—Somnolence—Pentoxifylline—malaria	0.000151	0.00079	CcSEcCtD
Lansoprazole—Urticaria—Quinine—malaria	0.00015	0.000784	CcSEcCtD
Lansoprazole—Urticaria—Quinidine—malaria	0.00015	0.000784	CcSEcCtD
Lansoprazole—Dyspepsia—Pentoxifylline—malaria	0.00015	0.000782	CcSEcCtD
Lansoprazole—Abdominal pain—Quinine—malaria	0.000149	0.00078	CcSEcCtD
Lansoprazole—Abdominal pain—Quinidine—malaria	0.000149	0.00078	CcSEcCtD
Lansoprazole—Body temperature increased—Quinine—malaria	0.000149	0.00078	CcSEcCtD
Lansoprazole—Body temperature increased—Quinidine—malaria	0.000149	0.00078	CcSEcCtD
Lansoprazole—Decreased appetite—Quinidine barbiturate—malaria	0.000148	0.000774	CcSEcCtD
Lansoprazole—Decreased appetite—Pentoxifylline—malaria	0.000148	0.000773	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000147	0.000769	CcSEcCtD
Lansoprazole—Pain—Quinidine barbiturate—malaria	0.000146	0.000761	CcSEcCtD
Lansoprazole—Constipation—Quinidine barbiturate—malaria	0.000146	0.000761	CcSEcCtD
Lansoprazole—Constipation—Pentoxifylline—malaria	0.000145	0.00076	CcSEcCtD
Lansoprazole—Hypersensitivity—Clindamycin—malaria	0.000142	0.000741	CcSEcCtD
Lansoprazole—Feeling abnormal—Quinidine barbiturate—malaria	0.00014	0.000734	CcSEcCtD
Lansoprazole—Feeling abnormal—Pentoxifylline—malaria	0.00014	0.000732	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000139	0.000728	CcSEcCtD
Lansoprazole—Hypersensitivity—Quinidine—malaria	0.000139	0.000727	CcSEcCtD
Lansoprazole—Hypersensitivity—Quinine—malaria	0.000139	0.000727	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Pentoxifylline—malaria	0.000139	0.000727	CcSEcCtD
Lansoprazole—Asthenia—Clindamycin—malaria	0.000138	0.000722	CcSEcCtD
Lansoprazole—Pruritus—Clindamycin—malaria	0.000136	0.000712	CcSEcCtD
Lansoprazole—Asthenia—Quinidine—malaria	0.000135	0.000708	CcSEcCtD
Lansoprazole—Asthenia—Quinine—malaria	0.000135	0.000708	CcSEcCtD
Lansoprazole—Urticaria—Quinidine barbiturate—malaria	0.000135	0.000707	CcSEcCtD
Lansoprazole—Urticaria—Pentoxifylline—malaria	0.000135	0.000706	CcSEcCtD
Lansoprazole—Abdominal pain—Quinidine barbiturate—malaria	0.000135	0.000704	CcSEcCtD
Lansoprazole—Body temperature increased—Quinidine barbiturate—malaria	0.000135	0.000704	CcSEcCtD
Lansoprazole—Abdominal pain—Pentoxifylline—malaria	0.000134	0.000703	CcSEcCtD
Lansoprazole—Body temperature increased—Pentoxifylline—malaria	0.000134	0.000703	CcSEcCtD
Lansoprazole—Pruritus—Quinine—malaria	0.000134	0.000698	CcSEcCtD
Lansoprazole—Pruritus—Quinidine—malaria	0.000134	0.000698	CcSEcCtD
Lansoprazole—Diarrhoea—Clindamycin—malaria	0.000132	0.000688	CcSEcCtD
Lansoprazole—Diarrhoea—Quinine—malaria	0.000129	0.000675	CcSEcCtD
Lansoprazole—Diarrhoea—Quinidine—malaria	0.000129	0.000675	CcSEcCtD
Lansoprazole—Dizziness—Clindamycin—malaria	0.000127	0.000665	CcSEcCtD
Lansoprazole—Vomiting—Dapsone—malaria	0.000126	0.000661	CcSEcCtD
Lansoprazole—Hypersensitivity—Quinidine barbiturate—malaria	0.000125	0.000656	CcSEcCtD
Lansoprazole—Hypersensitivity—Pentoxifylline—malaria	0.000125	0.000655	CcSEcCtD
Lansoprazole—Dizziness—Quinidine—malaria	0.000125	0.000652	CcSEcCtD
Lansoprazole—Dizziness—Quinine—malaria	0.000125	0.000652	CcSEcCtD
Lansoprazole—Headache—Dapsone—malaria	0.000125	0.000651	CcSEcCtD
Lansoprazole—Vomiting—Clindamycin—malaria	0.000122	0.000639	CcSEcCtD
Lansoprazole—Asthenia—Quinidine barbiturate—malaria	0.000122	0.000639	CcSEcCtD
Lansoprazole—Asthenia—Pentoxifylline—malaria	0.000122	0.000638	CcSEcCtD
Lansoprazole—Rash—Clindamycin—malaria	0.000121	0.000634	CcSEcCtD
Lansoprazole—Dermatitis—Clindamycin—malaria	0.000121	0.000634	CcSEcCtD
Lansoprazole—Headache—Clindamycin—malaria	0.000121	0.00063	CcSEcCtD
Lansoprazole—Pruritus—Quinidine barbiturate—malaria	0.000121	0.00063	CcSEcCtD
Lansoprazole—Pruritus—Pentoxifylline—malaria	0.00012	0.000629	CcSEcCtD
Lansoprazole—Vomiting—Quinidine—malaria	0.00012	0.000627	CcSEcCtD
Lansoprazole—Vomiting—Quinine—malaria	0.00012	0.000627	CcSEcCtD
Lansoprazole—Rash—Quinine—malaria	0.000119	0.000622	CcSEcCtD
Lansoprazole—Rash—Quinidine—malaria	0.000119	0.000622	CcSEcCtD
Lansoprazole—Dermatitis—Quinidine—malaria	0.000119	0.000622	CcSEcCtD
Lansoprazole—Dermatitis—Quinine—malaria	0.000119	0.000622	CcSEcCtD
Lansoprazole—Headache—Quinidine—malaria	0.000118	0.000618	CcSEcCtD
Lansoprazole—Headache—Quinine—malaria	0.000118	0.000618	CcSEcCtD
Lansoprazole—Nausea—Dapsone—malaria	0.000118	0.000618	CcSEcCtD
Lansoprazole—Diarrhoea—Quinidine barbiturate—malaria	0.000117	0.000609	CcSEcCtD
Lansoprazole—Diarrhoea—Pentoxifylline—malaria	0.000116	0.000608	CcSEcCtD
Lansoprazole—Nausea—Clindamycin—malaria	0.000114	0.000597	CcSEcCtD
Lansoprazole—Dizziness—Quinidine barbiturate—malaria	0.000113	0.000589	CcSEcCtD
Lansoprazole—Dizziness—Pentoxifylline—malaria	0.000112	0.000588	CcSEcCtD
Lansoprazole—Nausea—Quinine—malaria	0.000112	0.000586	CcSEcCtD
Lansoprazole—Nausea—Quinidine—malaria	0.000112	0.000586	CcSEcCtD
Lansoprazole—Vomiting—Quinidine barbiturate—malaria	0.000108	0.000566	CcSEcCtD
Lansoprazole—Vomiting—Pentoxifylline—malaria	0.000108	0.000565	CcSEcCtD
Lansoprazole—Rash—Quinidine barbiturate—malaria	0.000107	0.000561	CcSEcCtD
Lansoprazole—Dermatitis—Quinidine barbiturate—malaria	0.000107	0.000561	CcSEcCtD
Lansoprazole—Rash—Pentoxifylline—malaria	0.000107	0.00056	CcSEcCtD
Lansoprazole—Dermatitis—Pentoxifylline—malaria	0.000107	0.00056	CcSEcCtD
Lansoprazole—Headache—Quinidine barbiturate—malaria	0.000107	0.000558	CcSEcCtD
Lansoprazole—Headache—Pentoxifylline—malaria	0.000107	0.000557	CcSEcCtD
Lansoprazole—Nausea—Quinidine barbiturate—malaria	0.000101	0.000529	CcSEcCtD
Lansoprazole—Nausea—Pentoxifylline—malaria	0.000101	0.000528	CcSEcCtD
Lansoprazole—CYP4A11—Arachidonic acid metabolism—HPGDS—malaria	4.85e-05	0.0301	CbGpPWpGaD
Lansoprazole—ABCG2—Fluoropyrimidine Activity—DHFR—malaria	3.67e-05	0.0228	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—SLC4A1—malaria	3.6e-05	0.0223	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—HPGDS—malaria	3.34e-05	0.0207	CbGpPWpGaD
Lansoprazole—MAPT—IL-5 Signaling Pathway—IL2—malaria	3.23e-05	0.02	CbGpPWpGaD
Lansoprazole—MAPT—Alzheimers Disease—FAS—malaria	3.21e-05	0.0199	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—SLC4A1—malaria	3.21e-05	0.0199	CbGpPWpGaD
Lansoprazole—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—DECR1—malaria	3.17e-05	0.0197	CbGpPWpGaD
Lansoprazole—CYP1B1—Arachidonic acid metabolism—HPGDS—malaria	3.12e-05	0.0194	CbGpPWpGaD
Lansoprazole—MAPT—IL-2 Signaling Pathway—IL2—malaria	3.11e-05	0.0193	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	2.86e-05	0.0178	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	2.82e-05	0.0175	CbGpPWpGaD
Lansoprazole—CYP4A11—NRF2 pathway—G6PD—malaria	2.7e-05	0.0167	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—HPGDS—malaria	2.06e-05	0.0128	CbGpPWpGaD
Lansoprazole—ABCG2—HIF-2-alpha transcription factor network—KDR—malaria	1.93e-05	0.0119	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—CD36—malaria	1.92e-05	0.0119	CbGpPWpGaD
Lansoprazole—CYP1A1—Arachidonic acid metabolism—HPGDS—malaria	1.92e-05	0.0119	CbGpPWpGaD
Lansoprazole—MAPT—Alzheimers Disease—IL1B—malaria	1.88e-05	0.0117	CbGpPWpGaD
Lansoprazole—MAPT—Apoptosis—FAS—malaria	1.87e-05	0.0116	CbGpPWpGaD
Lansoprazole—CYP4A11—Biological oxidations—HPGDS—malaria	1.8e-05	0.0112	CbGpPWpGaD
Lansoprazole—CYP2C8—Arachidonic acid metabolism—HPGDS—malaria	1.76e-05	0.0109	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—FAS—malaria	1.76e-05	0.0109	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	1.74e-05	0.0108	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—FAS—malaria	1.59e-05	0.00984	CbGpPWpGaD
Lansoprazole—CYP2C18—Biological oxidations—HPGDS—malaria	1.58e-05	0.00978	CbGpPWpGaD
Lansoprazole—CYP2C19—Arachidonic acid metabolism—HPGDS—malaria	1.57e-05	0.00976	CbGpPWpGaD
Lansoprazole—CYP4A11—PPARA activates gene expression—CD36—malaria	1.49e-05	0.00922	CbGpPWpGaD
Lansoprazole—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—malaria	1.45e-05	0.00902	CbGpPWpGaD
Lansoprazole—CYP2C9—Arachidonic acid metabolism—HPGDS—malaria	1.43e-05	0.0089	CbGpPWpGaD
Lansoprazole—MAPT—Alzheimers Disease—TNF—malaria	1.36e-05	0.00847	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—malaria	1.31e-05	0.00813	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—DECR1—malaria	1.26e-05	0.00784	CbGpPWpGaD
Lansoprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—DECR1—malaria	1.26e-05	0.00781	CbGpPWpGaD
Lansoprazole—CYP1A2—Arachidonic acid metabolism—HPGDS—malaria	1.23e-05	0.00761	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	1.21e-05	0.00752	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—CD36—malaria	1.18e-05	0.00735	CbGpPWpGaD
Lansoprazole—CYP1B1—Biological oxidations—HPGDS—malaria	1.16e-05	0.00721	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	1.11e-05	0.00687	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	1.08e-05	0.00671	CbGpPWpGaD
Lansoprazole—ABCG2—HIF-1-alpha transcription factor network—NOS2—malaria	1.08e-05	0.00668	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	1.08e-05	0.00668	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—IL1B—malaria	1.03e-05	0.00638	CbGpPWpGaD
Lansoprazole—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	1e-05	0.00622	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL12B—malaria	9e-06	0.00558	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—DECR1—malaria	8.14e-06	0.00505	CbGpPWpGaD
Lansoprazole—MAPT—Apoptosis—TNF—malaria	7.96e-06	0.00494	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	7.85e-06	0.00487	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—TNF—malaria	7.85e-06	0.00487	CbGpPWpGaD
Lansoprazole—CYP1A2—Phase II conjugation—HPGDS—malaria	7.8e-06	0.00484	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—CD36—malaria	7.55e-06	0.00468	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC4A1—malaria	7.49e-06	0.00465	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	7.47e-06	0.00463	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—TNF—malaria	7.46e-06	0.00463	CbGpPWpGaD
Lansoprazole—CYP1A1—Biological oxidations—HPGDS—malaria	7.16e-06	0.00444	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—DHODH—malaria	7.04e-06	0.00437	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—HPGDS—malaria	6.92e-06	0.0043	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—TNF—malaria	6.74e-06	0.00418	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	6.66e-06	0.00413	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	6.64e-06	0.00412	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—CD40LG—malaria	6.58e-06	0.00408	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL10—malaria	6.58e-06	0.00408	CbGpPWpGaD
Lansoprazole—CYP2C8—Biological oxidations—HPGDS—malaria	6.56e-06	0.00407	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL4—malaria	6.4e-06	0.00397	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—SCARB1—malaria	6.36e-06	0.00394	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—HLA-B—malaria	6.26e-06	0.00388	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—DHODH—malaria	6.15e-06	0.00382	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—SLC4A1—malaria	5.99e-06	0.00371	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—FAS—malaria	5.9e-06	0.00366	CbGpPWpGaD
Lansoprazole—CYP1A1—PPARA activates gene expression—CD36—malaria	5.9e-06	0.00366	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—HPGDS—malaria	5.86e-06	0.00363	CbGpPWpGaD
Lansoprazole—ABCB1—HIF-1-alpha transcription factor network—NOS2—malaria	5.83e-06	0.00361	CbGpPWpGaD
Lansoprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—malaria	5.77e-06	0.00358	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—DECR1—malaria	5.63e-06	0.00349	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—HPGDS—malaria	5.39e-06	0.00334	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—HPGDS—malaria	5.34e-06	0.00331	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	5.26e-06	0.00326	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—SLC4A1—malaria	5.23e-06	0.00325	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—HBB—malaria	5.09e-06	0.00316	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—DECR1—malaria	5.02e-06	0.00311	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—DECR1—malaria	4.92e-06	0.00305	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	4.83e-06	0.003	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—malaria	4.83e-06	0.003	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	4.76e-06	0.00295	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—DECR1—malaria	4.6e-06	0.00285	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—HPGDS—malaria	4.56e-06	0.00283	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—DHODH—malaria	4.54e-06	0.00281	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PKLR—malaria	4.54e-06	0.00281	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—HPGDS—malaria	4.46e-06	0.00277	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—HBB—malaria	4.45e-06	0.00276	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	4.25e-06	0.00263	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	4.23e-06	0.00262	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—DHODH—malaria	4.13e-06	0.00256	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—DECR1—malaria	4.1e-06	0.00255	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—SCARB1—malaria	4.1e-06	0.00254	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	4.05e-06	0.00251	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—G6PD—malaria	4.04e-06	0.00251	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—CD36—malaria	3.99e-06	0.00248	CbGpPWpGaD
Lansoprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	3.98e-06	0.00247	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PKLR—malaria	3.97e-06	0.00246	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IFNG—malaria	3.87e-06	0.0024	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—SLC4A1—malaria	3.86e-06	0.00239	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—DECR1—malaria	3.74e-06	0.00232	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—DECR1—malaria	3.63e-06	0.00225	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—G6PD—malaria	3.53e-06	0.00219	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—HPGDS—malaria	3.52e-06	0.00218	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—SLC4A1—malaria	3.51e-06	0.00218	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL1B—malaria	3.45e-06	0.00214	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL2—malaria	3.44e-06	0.00213	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—DECR1—malaria	3.3e-06	0.00205	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—HBB—malaria	3.28e-06	0.00203	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	3.2e-06	0.00198	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—HPGDS—malaria	3.08e-06	0.00191	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	3.08e-06	0.00191	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malaria	3.08e-06	0.00191	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—HBB—malaria	2.98e-06	0.00185	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PKLR—malaria	2.92e-06	0.00181	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	2.91e-06	0.00181	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—DHFR—malaria	2.86e-06	0.00177	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—SCARB1—malaria	2.83e-06	0.00176	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—DHODH—malaria	2.79e-06	0.00173	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.75e-06	0.0017	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—HPGDS—malaria	2.7e-06	0.00167	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PKLR—malaria	2.66e-06	0.00165	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—G6PD—malaria	2.61e-06	0.00162	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—CD36—malaria	2.57e-06	0.00159	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—DHODH—malaria	2.56e-06	0.00159	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.52e-06	0.00157	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.52e-06	0.00156	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—TNF—malaria	2.5e-06	0.00155	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—DHFR—malaria	2.5e-06	0.00155	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—SCARB1—malaria	2.47e-06	0.00154	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—SLC4A1—malaria	2.38e-06	0.00147	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—G6PD—malaria	2.37e-06	0.00147	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.31e-06	0.00143	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—DHODH—malaria	2.29e-06	0.00142	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.25e-06	0.00139	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—DECR1—malaria	2.23e-06	0.00139	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—DHODH—malaria	2.23e-06	0.00138	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—SLC4A1—malaria	2.18e-06	0.00135	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—DHODH—malaria	2.1e-06	0.0013	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—DHODH—malaria	2.08e-06	0.00129	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.06e-06	0.00128	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.05e-06	0.00127	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—DECR1—malaria	2.05e-06	0.00127	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—HBB—malaria	2.02e-06	0.00125	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—HPGDS—malaria	1.99e-06	0.00123	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—SLC4A1—malaria	1.94e-06	0.00121	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—SLC4A1—malaria	1.9e-06	0.00118	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.88e-06	0.00117	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—HBB—malaria	1.85e-06	0.00115	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—DHFR—malaria	1.84e-06	0.00114	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—DECR1—malaria	1.83e-06	0.00113	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—SCARB1—malaria	1.82e-06	0.00113	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—HPGDS—malaria	1.81e-06	0.00112	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PKLR—malaria	1.8e-06	0.00112	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SLC4A1—malaria	1.79e-06	0.00111	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—DECR1—malaria	1.78e-06	0.00111	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—DHODH—malaria	1.78e-06	0.00111	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CD36—malaria	1.78e-06	0.0011	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SLC4A1—malaria	1.77e-06	0.0011	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.75e-06	0.00109	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—DECR1—malaria	1.68e-06	0.00104	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—DHFR—malaria	1.68e-06	0.00104	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—DECR1—malaria	1.67e-06	0.00103	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—SCARB1—malaria	1.66e-06	0.00103	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HBB—malaria	1.65e-06	0.00103	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PKLR—malaria	1.65e-06	0.00102	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HBB—malaria	1.61e-06	0.001	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.61e-06	0.000998	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—G6PD—malaria	1.6e-06	0.000995	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—CD36—malaria	1.58e-06	0.000982	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CD36—malaria	1.55e-06	0.000963	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HBB—malaria	1.52e-06	0.000943	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SLC4A1—malaria	1.51e-06	0.00094	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HBB—malaria	1.51e-06	0.000935	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PKLR—malaria	1.47e-06	0.000914	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—G6PD—malaria	1.47e-06	0.000913	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—CD36—malaria	1.45e-06	0.000901	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PKLR—malaria	1.44e-06	0.000892	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—DECR1—malaria	1.42e-06	0.000883	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—DHODH—malaria	1.37e-06	0.000853	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PKLR—malaria	1.36e-06	0.000841	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PKLR—malaria	1.34e-06	0.000833	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—G6PD—malaria	1.31e-06	0.000815	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CD36—malaria	1.3e-06	0.000804	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HBB—malaria	1.29e-06	0.000799	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—G6PD—malaria	1.28e-06	0.000795	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	1.24e-06	0.000767	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—HPGDS—malaria	1.22e-06	0.000759	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—G6PD—malaria	1.21e-06	0.000749	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—G6PD—malaria	1.2e-06	0.000743	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	1.18e-06	0.000733	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC4A1—malaria	1.17e-06	0.000725	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PKLR—malaria	1.15e-06	0.000712	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CD36—malaria	1.15e-06	0.00071	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—DHFR—malaria	1.14e-06	0.000704	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—SCARB1—malaria	1.12e-06	0.000697	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—HPGDS—malaria	1.12e-06	0.000696	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—DECR1—malaria	1.1e-06	0.000682	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CD36—malaria	1.04e-06	0.000646	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—DHFR—malaria	1.04e-06	0.000646	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—SCARB1—malaria	1.03e-06	0.000639	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—G6PD—malaria	1.02e-06	0.000635	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	1.01e-06	0.000626	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HPGDS—malaria	1e-06	0.000621	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HBB—malaria	9.94e-07	0.000617	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HPGDS—malaria	9.78e-07	0.000606	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—DHFR—malaria	9.29e-07	0.000576	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HPGDS—malaria	9.21e-07	0.000571	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—SCARB1—malaria	9.2e-07	0.00057	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HPGDS—malaria	9.13e-07	0.000566	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—DHFR—malaria	9.07e-07	0.000563	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—SCARB1—malaria	8.97e-07	0.000557	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PKLR—malaria	8.86e-07	0.00055	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—DHFR—malaria	8.55e-07	0.00053	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—DHFR—malaria	8.47e-07	0.000526	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SCARB1—malaria	8.46e-07	0.000525	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SCARB1—malaria	8.38e-07	0.00052	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—G6PD—malaria	7.9e-07	0.00049	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HPGDS—malaria	7.8e-07	0.000484	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—DHFR—malaria	7.24e-07	0.000449	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SCARB1—malaria	7.16e-07	0.000444	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CD36—malaria	7.05e-07	0.000437	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CD36—malaria	6.46e-07	0.000401	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HPGDS—malaria	6.02e-07	0.000374	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CD36—malaria	5.77e-07	0.000358	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CD36—malaria	5.63e-07	0.000349	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—DHFR—malaria	5.59e-07	0.000347	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SCARB1—malaria	5.53e-07	0.000343	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CD36—malaria	5.31e-07	0.000329	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CD36—malaria	5.26e-07	0.000326	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CD36—malaria	4.5e-07	0.000279	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CD36—malaria	3.47e-07	0.000215	CbGpPWpGaD
